Onderneming Kelyniam Global, Inc. Other OTC
Aandelen
KLYG
US4883591004
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Custom Prosthetic Cranial Implants
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -11,44% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 3 | 100,0 % | -11,44% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ross Bjella
CEO | Chief Executive Officer | - | 09-01-18 |
Director of Finance/CFO | - | 01-02-20 | |
Chief Operating Officer | - | 01-01-11 | |
Desiree Webb
BRD | Director/Board Member | - | - |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01-06-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Operating Officer | - | 01-01-11 | |
Mark V. Smith
PRN | Corporate Officer/Principal | - | 01-06-14 |
Ross Bjella
CEO | Chief Executive Officer | - | 09-01-18 |
Desiree Webb
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 29 923 145 | 16 022 500 ( 53,55 %) | 0 | 53,55 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,85% | 227 mld. | |
+13,88% | 192 mld. | |
+18,39% | 136 mld. | |
+28,78% | 108 mld. | |
+1,67% | 64,07 mld. | |
+18,24% | 52,1 mld. | |
+7,04% | 51,87 mld. | |
+10,83% | 44,33 mld. | |
+5,94% | 36,75 mld. |